Michael Heltzen is an experienced entrepreneur in the bioelectronics, precision medicine, digital biology, and omics space. He is passionate about the "Biology as Technology" movement and believes it will revolutionize the healthcare industry. With a deep fascination for molecular signals, Mr. Heltzen is committed to making a positive impact in these areas. He is an expert in talent development and designing winner company culture. Mr. Heltzen has an uncanny ability to find strategic opportunities and partnerships in the Omics/Precision Medicine/Digital Biology tech space. He has experience in business development, optimization, and financial management from operational, accounting, auditing, financing, investing, and fundraising perspectives.

Mr. Heltzen has an MBA summer school degree from ESSAM, Danish HHI at Skive Business College, an HD(R)2 from Aarhus School of Business - Uni. Of Aarhus, and a gymnasium degree from Geswister Scholl Gymnasium.

He has held many leadership roles including CEO at Cardea Bio Inc., Chairman & Investor at EXO Incubator, Chairman at BlueSEQ Innovations Inc., Seed Investor via Genomics Investment Syndicate/BlueSEQ at Private Equity and Investing, Chairman, CEO & Lead Investor at Nanosens Innovations Inc., "Mayor of Innovation", Board Member and Co-founder at Startup City Denmark, Board Member at Copenhagenomics Foundation at Copenhagenomics, Vice President at BGI Europe, Director of Partner Sales / Seed Investor at CLC bio (sold to NYSE:QGEN), Global Business Developer / Seed Investor at CLC bio A/S, Marketing & Financials / First Employee / Seed Investor at CLC bio A/S, and Auditor Trainee at Deloitte. He is also an experienced backpacker and sales associate. His international work, sales, and negotiation experiences in many different places around the world have given him a refined understanding of cultural and individual personality traits and motivational factors. He is now a permanent resident in the USA/California.

Mr. Heltzen's daily efforts include delivering leadership principles and mentorship, creating value and trust-based businesses, setting up, accelerating, and growing life science businesses and missions with talented groups of people. He excels in entrepreneurship and leadership combined with the newest knowledge about tech, humans, and biology. He always aims to take more action than talk, while still being a great communicator.